Objectives-To compare the adequacy of 23-, 25-, and 27-gauge needles in the fine-needle aspiration biopsy of thyroid nodules to develop guidelines for the collection of better specimens for cytologic diagnosis.
U ltrasound (US)-guided fine-needle aspiration biopsy (FNAB) offers high sensitivity and specificity in the identification of malignant thyroid nodules before surgical excision. 1 The first report of the application of FNAB to thyroid nodules was published in 1930, 2 and since then, physicians have attempted to develop methods for obtaining more aspirated material. The addition of US guidance for FNAB reduced the occurrence of nondiagnostic aspirations 3, 4 ; thus, US-guided FNAB became the recommended technique for evaluating thyroid nodules. 5 Ultrasound-guided FNAB causes nearly no morbidity, but sometimes patients have local pain and hemorrhage, [6] [7] [8] complications that are directly related to the size of the needle used. Originally and for many years, although large-core needles were used in the past, the current FNAB procedure uses needles ranging from 21 to 27 gauge. 9, 10 Despite the many advances in all aspects of cancer diagnosis, there are still no uniform standards for which the size and type of needle will allow for the optimal diagnosis and the least complications in FNAB. Moreover, even when performed by experienced physicians, approximately 15% of FNAB procedures are considered nondiagnostic. 11 Several factors potentially contribute to unsuccessful FNAB procedures in which an inadequate amount of aspirated material is collected; these include the characteristics of the nodule, the experience level of the pathologist, and the size of needle used. 12 Because needle size might be a key factor in the adequacy of FNAB as well as in reducing complications, we aimed to determine whether the adequacy of USguided FNAB specimens for cytologic diagnosis of thyroid nodules differs with the use of needles of differing sizes, in general and according to nodule characteristics. The results of our study may be helpful for the eventual establishment of standards for needle selection according to thyroid nodule characteristics.
Materials and Methods

Patients
The study included 156 patients with 156 nodules who underwent US-guided FNAB of thyroid nodules in our hospital. The study was approved by the Institutional Review Board of our hospital, and all patients provided written informed consent before the FNAB procedure.
Ultrasound-Guided FNAB Procedure All biopsies were performed by the same physician, who specialized in interventional US. The patient was maintained in the supine position with an extended neck. The skin overlying the nodule was sterilized with a povidone-iodine solution (Lircon, Shangdong, China), and 2% lidocaine (Beijing Yimin Pharmaceutical Company, Beijing, China) was used for local anesthesia. Three samples were taken from each nodule with 23-, 25-, and 27-gauge needles (BD Biosciences, Franklin Lakes, NJ; 1 sample per needle size). The sequence in which the needles were used was assigned randomly. The needle was inserted into the nodule with no vacuum aspiration and then moved back and forth for approximately 5 to 10 passes. The collected material was directly smeared on a glass slide and immediately fixed in 95% ethyl alcohol (Beijing Zhenyuminsheng Pharmaceutical Company, Beijing, China). Hematoxylin-eosin staining was applied for cytopathologic diagnosis. Reexamination of the neck by US after 30 minutes was necessary to confirm the absence of complications.
Cytopathologic Interpretation
Two pathologists blinded to the needle size assessed all specimens. The cytopathologic diagnosis was classified according to the Bethesda System as follows: nondiagnostic (I), benign (II), atypia of undetermined significance (III), suspicious for a follicular neoplasm (IV), suspicious for malignancy (V), or malignant (VI). 13 Above all, the adequacy of the specimen was considered the primary factor for final diagnosis. Nondiagnostic specimens were those that did not meet criteria for adequacy (the presence of at least 6 follicular cell groups, each containing 10-15 cells from at least 2 slides). 6 According to these criteria, the pathologists compared the 3 samples from FNABs collected with different-size needles and made a decision regarding adequacy. Then they determined which set gave rise to better cellular specimens. All slides were reviewed by the cytopathologists, and they determined the adequacy in consensus; when a disagreement occurred, the final decision was made after discussion between the pathologists.
Statistical Analysis
Data were analyzed with SPSS version 16.0 software (IBM Corporation, Armonk, NY). Quantitative data are presented as means, and qualitative data are presented as percentages. Qualitative data were compared by a v 2 test. All the tests were 2 tailed, and P < .05 was considered statistically significant.
Results
The mean age of the 156 patients with 156 nodules was 48.7 years (range, 23-84 years). The ratio of men to women was 2.3:1. The nodules ranged in diameter from 3 to 42 mm (mean 6 SD, 10 6 6 mm). The nodules were classified into 3 categories according to their characteristic US findings: 60 (38.5%) nodules were hypoechoic; 50 (32.1%) were heterogeneous; and 46 (29.5%) were hyperechoic. None of the patients had bleeding after the procedures.
Among all 156 nodules, no statistically significant differences in adequacy were observed among USguided FNABs performed with the 23-, 25-, and 27-gauge needles (Table 1) . However, for each needle size, the adequacy of US-guided FNAB of hyperechoic nodules was significantly higher than that of hypoechoic samples (Table 2) . Moreover, the adequacy of USguided FNAB of hyperechoic nodules performed with the 23-gauge needle was significantly higher than that for heterogeneous nodules (Table 2 ). When we grouped the nodules according to size (<5, 5-10, and >10 mm), the adequacy rates of US-guided FNAB with the 23-, 25-, and 27-gauge needles did not differ among nodules in these size ranges (Table 3 ).
Discussion
Although a few studies have evaluated the use of different types of needles with or without aspiration in thyroid nodules (mostly from 21 to 27 gauge), [14] [15] [16] [17] and some researchers have recommended the use of fine needles for FNAB of thyroid nodules, there are still no wellaccepted procedural guidelines for obtaining optimal specimens for diagnostic use. Previous studies reported that 21-gauge needles can provide more cellular material than 25-and 27-gauge needles 1, 15 but showed no difference in terms of the adequacy rates for these needles. The presence of red blood cells could obscure the results and may explain why no differences in adequacy were observed. Therefore, we conducted a study in a large cohort to compare the adequacy of FNAB using fine needles (23, 25, and 27 gauge).
The most important finding of our study was that there were no significant differences in terms of adequacy among specimens collected with the 23-, 25-, and 27-gauge needles. We propose that although the finer needle collects less material, it yields an aspirate with less hemorrhagic components. Therefore, based on our findings, the 27-gauge needle seems to be the most appropriate among those tested for FNAB of thyroid nodules because specimens adequate for cytologic diagnosis were obtained with less bleeding and presumably less pain.
Another interesting observation of our study was that the inadequacy rate of FNAB for hypoechoic nodules was similar to that for heterogeneous nodules but higher than that for hyperechoic nodules. These findings are consistent with a previous study. 15 Theoretically, heterogeneous and hypoechoic nodules may be associated with more fibrosis, hemorrhagic structures, and other factors, and our results indicate similarities within the structures of heterogeneous and hypoechoic nodules. Notably, all 3 needle sizes provided approximately the same adequacy for nodules of differing sizes. The 23-, 25-, and 27-gauge needles used in this study are fine needles that rarely cause bleeding. In our study, each patient was subjected to FNAB without vacuum aspiration using the 3 different needle sizes, and no bleeding was observed. In addition to minimal bleeding, finer needles are more comfortable for patients. Unfortunately, because our patients were routinely offered local anesthesia regardless of the needle size, we could not quantify their level of pain and compare pain scores according to needle size. This factor was one limitation of the study. Not only is the use of a smaller needle more acceptable to patients and physicians compared to larger needles, it can save time by avoiding the need for additional FNAB and reduce the workload of cytopathologists. Confirmation of these benefits of the finer needle is warranted in future studies.
In conclusion, US-guided FNAB of thyroid nodules performed with 23-, 25-, and 27-gauge needles showed that the 27-gauge needle can be used to aspirate adequate specimens for diagnosis. Thus, the 27-gauge needle may be recommended for US-guided FNAB of thyroid nodules. Further studies are required to explore the use of finer needles for US-guided FNAB of the lymph nodes, breast, and other tissues that may require more material for pathologic diagnosis. In addition, the effects of vacuum force during US-guided FNAB with a 27-gauge needle should be investigated in future studies. Overall, a larger study is needed to address these issues and identify an optimal FNAB procedure.
